GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Clinica Baviera SA (LTS:0GWJ) » Definitions » Debt-to-EBITDA

Clinica Baviera (LTS:0GWJ) Debt-to-EBITDA : 0.66 (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Clinica Baviera Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Clinica Baviera's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €10.8 Mil. Clinica Baviera's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €36.7 Mil. Clinica Baviera's annualized EBITDA for the quarter that ended in Dec. 2023 was €72.1 Mil. Clinica Baviera's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 0.66.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Clinica Baviera's Debt-to-EBITDA or its related term are showing as below:

LTS:0GWJ' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.61   Med: 0.99   Max: 1.7
Current: 1.59

During the past 13 years, the highest Debt-to-EBITDA Ratio of Clinica Baviera was 1.70. The lowest was 0.61. And the median was 0.99.

LTS:0GWJ's Debt-to-EBITDA is ranked better than
53.92% of 102 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.79 vs LTS:0GWJ: 1.59

Clinica Baviera Debt-to-EBITDA Historical Data

The historical data trend for Clinica Baviera's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clinica Baviera Debt-to-EBITDA Chart

Clinica Baviera Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.70 1.60 0.97 0.85 0.71

Clinica Baviera Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.05 1.01 N/A 0.99 0.66

Competitive Comparison of Clinica Baviera's Debt-to-EBITDA

For the Diagnostics & Research subindustry, Clinica Baviera's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Clinica Baviera's Debt-to-EBITDA Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Clinica Baviera's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Clinica Baviera's Debt-to-EBITDA falls into.



Clinica Baviera Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Clinica Baviera's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(10.755 + 36.66) / 67.205
=0.71

Clinica Baviera's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(10.755 + 36.66) / 72.1
=0.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


Clinica Baviera  (LTS:0GWJ) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Clinica Baviera Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Clinica Baviera's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Clinica Baviera (LTS:0GWJ) Business Description

Traded in Other Exchanges
Address
Paseo de la Castellana 20, Madrid, ESP, 28046
Clinica Baviera SA operates ophthalmological clinics. It is involved in the diagnosis, treatment, and monitoring of various types of ophthalmological disorders. It offers diagnosis and treatment for various eye problems such as long-sightedness, short-sightedness, astigmatism, cataracts and eye strain.

Clinica Baviera (LTS:0GWJ) Headlines

No Headlines